Open Access Government

Join HT in funding a breakthrough in clinical genomics

Haploid Technologies has developed a groundbreaking new technology that enables precise assignment of phase across multiple ...
ascopubs.org

Assessment of Functional Status of Human Leukocyte Antigen Class I Genes in Cancer Tissues in the Context of Personalized Neoantigen Peptide Vaccine Immunotherapy

Somatic mutations in HLA genes were detected in the tumor data of five patients, and somatic HLA gene loss of heterozygosity was identified in the tumor data of five patients. Complete or partial ...
Nasdaq

NPJ Precision Oncology Publishes Tempus Study on Validation of its HLA-LOH Investigational Assay

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that the validation study of ...
Open Access Government

Be involved in funding an exciting new technology for clinical medicine

Brian Tait calls for public support to fund exciting groundbreaking technology for assigning phase to multiple mutations ...